FRISINA, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 5.703
EU - Europa 5.430
AS - Asia 3.130
SA - Sud America 1.187
AF - Africa 81
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.540
Nazione #
US - Stati Uniti d'America 5.591
RU - Federazione Russa 1.793
SG - Singapore 1.317
BR - Brasile 1.047
CN - Cina 1.015
SE - Svezia 959
IE - Irlanda 917
DE - Germania 548
UA - Ucraina 397
HK - Hong Kong 362
FI - Finlandia 257
GB - Regno Unito 188
VN - Vietnam 156
IT - Italia 125
FR - Francia 98
CA - Canada 63
IN - India 63
AR - Argentina 45
TR - Turchia 40
PL - Polonia 33
BE - Belgio 28
MX - Messico 28
EC - Ecuador 27
ZA - Sudafrica 24
BD - Bangladesh 23
VE - Venezuela 23
CZ - Repubblica Ceca 18
IQ - Iraq 18
IR - Iran 16
UY - Uruguay 14
AT - Austria 13
JP - Giappone 13
MA - Marocco 13
ID - Indonesia 12
PK - Pakistan 12
UZ - Uzbekistan 11
JO - Giordania 10
CO - Colombia 9
EG - Egitto 9
ES - Italia 9
KE - Kenya 9
NL - Olanda 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 7
CI - Costa d'Avorio 7
CL - Cile 7
NP - Nepal 7
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
LT - Lituania 6
PE - Perù 6
BG - Bulgaria 5
KZ - Kazakistan 5
PA - Panama 5
SN - Senegal 5
AL - Albania 4
CH - Svizzera 4
CR - Costa Rica 4
IL - Israele 4
OM - Oman 4
PY - Paraguay 4
AU - Australia 3
BO - Bolivia 3
DK - Danimarca 3
EE - Estonia 3
EU - Europa 3
GE - Georgia 3
HN - Honduras 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
BN - Brunei Darussalam 2
GY - Guiana 2
JM - Giamaica 2
KR - Corea 2
LK - Sri Lanka 2
LV - Lettonia 2
MN - Mongolia 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
AM - Armenia 1
BH - Bahrain 1
CY - Cipro 1
DZ - Algeria 1
GI - Gibilterra 1
GR - Grecia 1
HU - Ungheria 1
KH - Cambogia 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
MY - Malesia 1
NO - Norvegia 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TM - Turkmenistan 1
Totale 15.539
Città #
Dublin 917
Moscow 914
Jacksonville 847
Chandler 778
Singapore 648
Dallas 610
Ashburn 584
Nyköping 456
Beijing 420
Hong Kong 360
Munich 177
Los Angeles 159
The Dalles 159
Cambridge 150
Princeton 150
Medford 141
Des Moines 120
Ann Arbor 114
Boardman 108
New York 102
Dearborn 86
São Paulo 71
Helsinki 70
Buffalo 62
Lancaster 61
Ho Chi Minh City 55
Bremen 52
Shenyang 48
Jinan 47
Wilmington 47
Woodbridge 45
Tianjin 39
Hanoi 38
Turku 34
Redondo Beach 33
Zhengzhou 32
Belo Horizonte 30
Rio de Janeiro 29
Brussels 28
Frankfurt am Main 28
Hebei 28
San Mateo 27
Nanjing 26
Houston 24
Turin 23
Montreal 22
Pune 22
Taizhou 22
Haikou 21
Johannesburg 20
Santa Clara 20
Ningbo 19
Augusta 18
Boston 18
Düsseldorf 18
Hangzhou 18
Ottawa 18
Warsaw 17
Brno 16
Guangzhou 16
Porto Alegre 16
San Francisco 16
Seattle 16
Campinas 15
Curitiba 15
Poplar 15
Stockholm 15
Changsha 13
Lanzhou 13
London 13
Taiyuan 13
Atlanta 12
Brooklyn 12
Chennai 12
Denver 12
Guayaquil 12
Lauterbourg 12
Nanchang 12
Quito 12
Santo André 12
Tokyo 12
Falls Church 11
Jiaxing 11
Amman 10
Ardabil 10
Brasília 10
Chicago 10
Leawood 10
Orem 10
Recife 10
Fuzhou 9
Hyderabad 9
Istanbul 9
Monmouth Junction 9
Nuremberg 9
Ribeirão Preto 9
Sorocaba 9
Tashkent 9
Ankara 8
Baghdad 8
Totale 9.722
Nome #
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 254
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 185
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 170
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 164
Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women. 163
AQP1 in red blood cells of uremic patients during hemodialytic treatment 162
Aquaporin-2 water channels in spontaneously hypertensive rats 161
Cell proliferation/cell death balance in renal cell cultures after exposure to a static magnetic field 159
Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds 154
ASSETTO EMATOLOGICO DI UN GRUPPO DI SOGGETTIAFFETTI DA MORBO DI COOLEY:STUDIO DEL COMPORTAMENTO DELL'ERITROPOIETINA PLASMATICA 151
Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock 147
Circadian rhythm of hydration in healthy subjects and uremic patients studied by bioelectrical impedance analysis 147
Effects of Homocysteine on Proliferation, Necrosis, and Apoptosis of Vascular Smooth Muscle Cells in Culture and Influence of Folic Acid 146
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 145
Alterations in induced potassium calcium efflux in the erythrocytes of patients with autosomal dominant polycystic kidney disease and hypertension 144
Are there potential non-lipid-lowering uses of statins in the kidney? 144
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 142
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 142
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 141
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 140
Correlation between quality of life assessment and a personality neurobiologic model in dialyzed patients 138
Does captopril have a direct pro-apoptotic effect? 138
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 133
Association of primary hyperparathyoidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service. 130
Association between primary hyperprathyroidism (p-hyperPTH) and nodular toxic goiter (NTG): a prospective study at an outpatient service for osteoporosis 130
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 130
Cold pressor test raises serum concentrations of ICAM-1, VCAM- 1, and E-selectin in normotensive and hypertensive patients 130
Cardiovascular effects of raloxifene hydrochloride 129
A trigonometric approximation method for the monostatic radar cross section 129
Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients 129
Recombinant erythropoietin and hypertension 129
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 127
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 125
Effect of two different models of hemodiafiltration potassium removal on QT dispersion 124
Chromosomal damage and atherosclerosis. A protective effect from simvastatin. 124
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 123
Statins in the prevention of cardiovascular events in patients with renal failure. 122
Aldosterone and prolactin secretion. II. Plasma renin activity, blood potassium and cortisol levels following administration of sulpiride in normal subjects 122
Cardiorenal consequences of atherosclerosis and statins therapy: From the past to the future 122
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 120
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 120
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 120
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 119
SICUREZZA ED EFFICACIA DELLA GENISTEINA IN DONNE OSTEOPENICHE IN POSTMENOPAUSA 118
Hashimoto's thyroiditis is a frequent association of primary hyperparathyroidism, of which it modifies biochemical and bone density indices 118
Therapy with vasopressin receptor antagonists: the aquaretics 118
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women 117
Hashimoto's thyroiditis (HT) is a frequent association of primary hyperparathyroidism (p-hyperPTH), of which it modifies biochemical and bone density indices 113
The effect of two different protocols of potassium haemodiafiltration on QT dispersion 112
Effetti dell'alendronato sul Sister Chromatid Exchanges (SCE) in pazienti con osteoporosi post-menopausale (dati preliminari). 112
Effetti di un fitoestrogeno (Genisteina) su marcatori citogenetici in donne in post menopausa. 112
Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study 112
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 111
The behaviour of serum triiodothyronine in autonomous thyroid nodules and its relationship with the clinical feature 111
Osteoprotegerin, IL-6, IL-1, TNF-alpha and TGF-beta concentrations during acetate-free biofiltration 110
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 110
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 110
Effect of a prostacyclin analogue, iloprost, on urinary aquaporin-2 excretion in humans 110
ELIZABETHAN STUDIES IN ITALY IN 1989 AND 1990 109
Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray. 109
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 109
Oxidative stress and uremia 109
Effect of unsaturated fatty acids on basal plasma renin activity and afterpostural stimulation 108
Nonrobertsonian translocation t(6;11) is associated with infertility in an oligoazoospermic male 108
Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of K+ in erythrocytes from subjects with essential hypertension 107
L'azione di un bolo di rHu-EPO sul flusso muscolare di soggetti uremici 107
Statins in nephrotic syndrome: a new weapon against tissue injury. 106
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 106
Increased indexes of thrombin activation in advanced stages of hypertension 106
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 106
Erythropoietin and the brain: from neurodevelopment to neuroprotection 105
Cardiovascular remodeling, apoptosis, and drugs 105
ATTIVITÀ RENINICA, ANGIOTENSINA II, ALDOSTERONE PLASMATICI IN SOGGETTI ANZIANI. 105
Reduced bcl-2 concentrations in hypertensive patients after lisinopril or nifedipine administration 104
Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate. EUROPEAN UROLOGY, vol. 47; p. 575 - 581 103
EFFICACY AND TOLERABILITY OF AURANOFIN IN RHEUMATOID-ARTHRITIS - 2 YEARS FOLLOW-UP 102
Effect of a calcium antagonist, nifedipine, on the cold pressor test in normal subjects 101
Kidney aging: From phenotype to genetics 101
THE CIRCADIAN-RHYTHM OF ERYTHROPOIETIN IN SUBJECTS WITH PRE- TERMINAL UREMIA 100
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 100
From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine 100
The pleiotropic effects of erythropoietin in the central nervous system 99
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 99
Effects of lisinopril administration on blood bcl-2 concentrations in patients with immunoglobulin A nephropathy 99
Management of patients after renal graft loss: an open question for nephrologists. 98
Statins and progressive renal disease 97
Effetti del raloxifene sulla secrezione ipofisaria in post-menopausa 96
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 96
Loss of circadian rhythm in erythropoietin production in a patient with renal erythropoietin secreting neoplasia 94
Flushing due to calcitonin and the opioid system 92
DIFFERENT ANSWER TO RECOMBINANT-HUMAN-ERYTHROPOIETIN IN ANEPHRIC AND NONANEPHRIC HEMODIALYZED PATIENTS 91
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major 91
Endothelin-1 production in umbilical arteries from hypertensive pregnant women 90
Gastro-intestinal permeability is increased in patients with limited systemic sclerosis 89
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. 88
Plasma and erythrocyte magnesium concentrations in essential arterial hypertension 88
MARKERS OF ENDOTHELIAL AND PLATELET STATUS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND PLYCYTHEMIA VERA 87
Positive effects of the phytoestrogen genistein on bone metabolism in postmenopausal women 87
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients 86
DOES ERYTHROPOIETIN AUGMENT THE CA2+-MEDIATED K+ FLOW INTO THE RED-BLOOD-CELLS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS 86
Totale 11.937
Categoria #
all - tutte 54.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.853


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021483 0 0 0 0 0 135 4 109 0 69 124 42
2021/20221.213 5 263 13 26 62 10 59 39 56 225 133 322
2022/20232.829 203 272 128 221 251 279 25 193 1.107 34 85 31
2023/2024619 48 99 41 58 35 154 26 34 4 35 9 76
2024/20253.105 60 25 46 189 114 132 92 695 762 188 306 496
2025/20264.865 437 650 592 592 661 1.933 0 0 0 0 0 0
Totale 15.601